PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|September 15, 2014
Gerresheimer Presents Innovative Packaging Solution in Plastic and Glass at CPhI
Author(s)Pharmaceutical Technology Editors
Gerresheimer will present ready-to-fill syringes, plastic packaging products, and pharmaceutical vials at CPhI 2014.
Advertisement
Gerresheimer will showcase innovative glass and plastic packaging solutions for the pharmaceutical industry in the Innopack exhibition area at booth G55 in Hall 2 at CPhI 2014. The products range from pharmaceutical vials to complex drug delivery systems. Two Gerresheimer experts will give presentations on ready-to-fill sterile syringes. The syringe systems will be highlighted by Bernd Zeiss, technical presales support manager at Gerresheimer Syringe Systems, at 3 p.m. on Oct. 7, 2014. Zeiss will explain why the syringe systems are ideal for biotech, ophthalmology applications, and for home use.
The Gerresheimer Group offers a portfolio of pharmaceutical primary packaging products and syringes made from glass and COP (cyclic olefin polymer), including the Gx RTF sterile syringe systems.
Source:
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement